Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DOXERCALCIFEROL, with a corresponding US DMF Number 22136.
Remarkably, this DMF maintains an Active status since its submission on October 31, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 09, 2013, and payment made on December 20, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II